Biology remains a wide-open field because it has accomplished a lot but still has a long way to go. The dominant view in cellular behavior, for example, has been that it is largely chemistry-driven…

CALGARY, Canada, June 5 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that that it has started patient enrolment in a Phase II clinical trial using…

LONDON, June 5 /PRNewswire/ -- - With Photo Former England footballer, Geoff Thomas is pressing the Government for urgently needed cash to develop and deliver new leukaemia treatments. Thomas, a…

CALGARY, Canada, June 5 /PRNewswire/ -- - Company Achieves Important Milestone in Development of Next Generation Cardiovascular Drug SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company…

GENEVA, Switzerland, June 5 /PRNewswire/ -- - Trial in Systemic Lupus Erythematosus (SLE) Intended to Form Part of Potential Registration Package Merck Serono, a division of Merck KGaA, Darmstadt,…

Kylie Minogue's breast cancer triggered a surge of over 30 percent in breast imaging of low risk women, says new University of Melbourne study. Use of mammography and breast ultrasound procedures…

BERLIN, June 4 /PRNewswire/ -- - The 4th International Forum on Disability Management Will be Held in Berlin from 22 to 24 September. How can businesses retain employees' capacity for work following…

Synthetic molecules designed by two Hebrew University of Jerusalem researchers have succeeded in reducing and even eliminating the growth of human malignant tissues in mice, while having no toxic…

SAN DIEGO, June 3 /PRNewswire/ -- - Acquisition Expected to Accelerate Gen-Probe's Commercial Expansion in Fast-Growing European Market; Add Complementary Products, Technologies and Markers - -…

LEUVEN, Belgium and LUND, Sweden, June 3 /PRNewswire/ -- - Approval Also Received to Start Second Repeat-Dose Phase I Study in Patients With Advanced Cancer ThromboGenics NV (Euronext Brussels: THR…